Frontlight ResearchEarly access
WithdrawnPhase 2
N2O for Acute Suicidality and Depression in the ED
Key facts
- Who runs it
- University of Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Phase
- Phase 2
- Started
- 27 Feb 2026
- Ended
- 27 Feb 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Nitrous oxide gas for inhalation
- Placebo
- Record updated
- 4 March 2026
- Why it stopped
- PI has left the university
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Patients 18-65 years of age, acutely suicidal, presenting to the adult emergency department with documented history of non-psychotic major depressive disorder
Who cannot take part
- Chronic cobalamin and/or folate deficiency treated with folic acid or vitamin B12
- Lifetime DSM-V (medical history) diagnoses of schizophrenia, schizoaffective disorders, bipolar disorder, obsessive-compulsive disorder, and panic disorders
- Meets current DSM-V substance use disorder of greater than mild severity (other than nicotine or marijuana)
- Significant pulmonary disease and/or requiring supplemental oxygen
- Current psychotic or catatonic symptoms as determined by the hospital care team
- Unable or unwilling to give consent for study participation (ability to provide consent will be established by treating physician)
- Administration of other NMDA-receptor antagonist treatment (e.g., ketamine) within two weeks of entry into study
- Contraindications for N2O (pneumothorax, bowel obstruction, middle ear occlusion, elevated intracranial pressure)
- Women who are pregnant or breastfeeding
- Any other factor that in the investigators' judgment may affect patient safety or compliance
Where in United States
- University of Chicago MedicineChicago, United States
About the trial
What the trial wants to find out
Investigators are conducting this double-blind, randomized control trial (RCT), to compare inhaled N2O+ treatment as usual (TAU) versus inhaled placebo+TAU; demonstrating the feasibility and tolerability of the intervention in an emergency department (ED) setting on an acutely suicidal population.
The 2 groups in the trial
- Treatment; Nitrous Oxide 50%Existing treatment, for comparison
A single 45-minute session of inhaled 50% nitrous oxide.
Treatment: Nitrous oxide gas for inhalation
- Control; Oxygen-air mixturePlacebo, for comparison
A single 45-minute session of inhaled Oxygen-air mixture
Treatment: Placebo
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Inhaled Nitrous Oxide for Acute Suicidality and Depression in the Emergency Department
- Record updated
- 4 March 2026